Factors related to the efficacy of skeletal muscle cell transplantation and future approaches with control-released cell growth factors and minimally invasive surgery.
Tambara
Keiichi
K
Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tabata
Yasuhiko
Y
Komeda
Masashi
M
D000818:Animals; D003692:Delayed-Action Preparations; D004195:Disease Models, Animal; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000627:therapeutic use*; D006352:Heart Ventricles / Q000187:drug effects / Q000473:pathology; D017228:Hepatocyte Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D019060:Minimally Invasive Surgical Procedures; D032448:Myoblasts, Skeletal / Q000187:drug effects / Q000637:transplantation*; D009203:Myocardial Infarction / Q000601:surgery*; D032383:Myocytes, Cardiac / Q000637:transplantation; D018919:Neovascularization, Physiologic / Q000187:drug effects; D011897:Random Allocation; D051381:Rats; D011917:Rats, Inbred Lew; D013552:Swine; D020257:Ventricular Remodeling / Q000502:physiology
D003692:Delayed-Action Preparations; D016222:Fibroblast Growth Factor 2; D017228:Hepatocyte Growth Factor